FGF21 Inflammation associated with indicators of nutritional status in patients with IBD

Published Date: 03 Mar 2023

FGF21 Inflammation associated with indicators of nutritional status in patients with IBD

Read Full News

Latest News

SIBO Tied to Higher Bile Acid Synthesis in Patients With Chronic Diarrhea

SIBO Tied to Higher Bile Acid Synthesis in Patients With Chronic Diarrhea

Antifungal Therapy Eased IBD Activity, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

Fluconazole was linked to improved Mayo and Harvey-Bradshaw scores; Iliev outlines the placebo-controlled trial needed next.

Dupilumab Improves Esophageal Distensibility in EoE: REMODEL Trial Evan Dellon, MD, MPH

Evan Dellon, MD, MPH, discusses REMODEL data showing dupilumab widened the esophagus vs placebo, with the biggest gains in patients with narrower caliber.

Multilevel Intervention Improves CRC Screening, With Aasma Shaukat, MD, MPH

Multilevel Intervention Improves CRC Screening, With Aasma Shaukat, MD, MPH

Fertility Treatment in IBD: Insights From the WIsDoM Cohort Eugenia Shmidt, MD, Zoë Gottlieb, MD

Eugenia Shmidt, MD, and Zoë Gottlieb, MD, discuss WIsDoM data showing 73% of women with IBD conceived with fertility treatment, most via embryo transfer.

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

David T. Rubin, MD, on the questions, screening tools, and system barriers standing between IBD care and the whole patient.

Todays Updates

Episode 177: Previewing the 2026 NEALS Annual Meeting Marco Meglio, Jinsy A. Andrews, MD, MSc, Nicholas Maragakis, MD

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Nicholas J. Maragakis, MD; and Jinsy Andrews, MD, MSc, FAAN, FANA. [LISTEN TIME: 23 minutes]

Todays Updates

Episode 177: Previewing the 2026 NEALS Annual Meeting Marco Meglio, Jinsy A. Andrews, MD, MSc, Nicholas Maragakis, MD

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Nicholas J. Maragakis, MD; and Jinsy Andrews, MD, MSc, FAAN, FANA. [LISTEN TIME: 23 minutes]

Latest News

SIBO Tied to Higher Bile Acid Synthesis in Patients With Chronic Diarrhea

Fluconazole was linked to improved Mayo and Harvey-Bradshaw scores; Iliev outlines the placebo-controlled trial needed next.

Evan Dellon, MD, MPH, discusses REMODEL data showing dupilumab widened the esophagus vs placebo, with the biggest gains in patients with narrower caliber.

Multilevel Intervention Improves CRC Screening, With Aasma Shaukat, MD, MPH

Eugenia Shmidt, MD, and Zoë Gottlieb, MD, discuss WIsDoM data showing 73% of women with IBD conceived with fertility treatment, most via embryo transfer.

David T. Rubin, MD, on the questions, screening tools, and system barriers standing between IBD care and the whole patient.

News All Time

Optimizing IBD Treatment and Sequencing, With Jordan Axelrad, MD, MPH Jordan Axelrad, MD, MPH

Jordan Axelrad, MD, MPH, discusses first-line IBD therapy selection, sequencing after failure, treat-to-target monitoring, and evaluating new agents

When IBD Symptoms Don't Match Inflammation, With Jordan Axelrad, MD, MPH Jordan Axelrad, MD, MPH

A gastroenterologist explains why IBD symptoms don't always signal a flare, the biomarkers used to confirm inflammation, and counseling patients through Crohn's disease.

ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis

ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis

5 Gastroenterology Headlines You Missed in September 2026

5 Gastroenterology Headlines You Missed in September 2026

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Targeting Gut Candida to Treat IBD, With Iliyan D. Iliev, PhD

Targeting Gut Candida to Treat IBD, With Iliyan D. Iliev, PhD

FDA Expansion of Linaclotide for Children 2-5 Years With Functional Constipation Julie Khlevner, MD, AGAF

Khlevner, MD, discusses the expanded FDA approval of linaclotide for children aged ≥2 years with functional constipation.

6 Gastroenterology Headlines You Missed in May 2026 Abigail Brooks, MA

Catch up on GI regulatory actions and top headlines from DDW in this May month in review.

Obefazimod Sustains Remission After Dose Reduction in UC Extension Trial Abigail Brooks, MA

Study 108 interim data show 68% of UC patients remained in clinical remission at week 144 after de-escalating from 50 mg to 25 mg obefazimod daily.

The HCPFive: Top News for Healthcare Providers from the Week of 05/24 HCPLive Editorial Staff

Stay updated with the latest healthcare breakthroughs, including FDA approvals and phase 3 data.

Tulisokibart Meets Phase 3 Endpoints in Ulcerative Colitis, First for Anti-TL1A Alex Hillenbrand

Tulisokibart became the first anti-TL1A therapy to achieve clinical remission in a phase 3 ulcerative colitis trial.

Obefazimod Delivers Week 44 Remission in Refractory UC Patients Alex Hillenbrand

Abivax’s ABTECT Part 2 showed Week 44 responses and safety consistency with obefazimod in refractory UC patients.

The HCPFive: Top News for Healthcare Providers from the Week of 06/21 HCPLive Editorial Staff

Stay updated with the latest healthcare breakthroughs, including phase 3 data, new clinical findings, and regulatory updates.

Abdominal Pain and Bloating: When to Consider HAE, MCAS, and EGIDs Brian Lacy, MD, PhD

Gastroenterologist Brian Lacy, MD, PhD, discusses how to differentiate HAE, MCAS, and eosinophilic GI disorders in patients with unexplained abdominal pain and bloating.

When Abdominal Pain Is Actually a Food Allergy: A GI Workup Brian Lacy, MD, PhD

Brian Lacy, MD, PhD, of Mayo Clinic discussed the stepwise approach to diagnosing non-IgE mediated food hypersensitivity at EAC 2026.

First Half 2026 Recap: Gastroenterology Alex Hillenbrand

Review the biggest gastroenterology news from the first half of 2026, including FDA updates, IBD advances, and key clinical trials.

Recommended News For You

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

Could Burnout Become the Employer’s Responsibility?

New surgical method shows promising results for cervical cancer treatment

Unlocking the potential of targeted therapies for multiple myeloma

Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

Recommended Articles For You

Quality of Life Through Maintaining Functional Independence During Chronic Hematologic Conditions 

Targeting Iron Recycling Pathways in Hematologic Disease 

Multi-Cancer Risk Stratification Through Precision Screening 

Nuclear Medicine's Role in Battling Women's Cancers 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

2.

Triplet Could Become a New Standard in Tough-to-Treat CLL

3.

Dasatinib Fails to Improve Outcomes in CBF-AML

4.

Financial hardship common in patients with cancer

5.

New study links air pollution with higher rates of head and neck cancer

1.

Remote Hematology Follow-Up: Advancements, Clinical Implications, and Future Directions

2.

Red Blood Cell Aging and Clinical Implications

3.

Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation

4.

Tumor Evolution Under Treatment Pressure: Real-Time Tracking of Resistance and Clonal Selection

5.

A Visual Journey Through Penile Cancer: Examining the Impact of Photos

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Cancer Care: From Awareness to Recovery

2.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

3.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

4.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

5.

Efficient Management of First line ALK-rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot